Status:
UNKNOWN
The Value of HPV Testing for Cervical Cancer Screening in Women Living With HIV (PAPILLO-VIH)
Lead Sponsor:
Centre Hospitalier de Saint-Denis
Conditions:
HIV Seropositivity
Eligibility:
FEMALE
25-65 years
Brief Summary
The main objective of this study is to evaluate the interest of a screening strategy based on the HPV test in patients living with HIV, compared to the cell smear alone in the same population. The Se...
Detailed Description
Since 2019, a new screening strategy has been implemented and is based on high-risk, HPV tests, which, when negative, allow for spaced monitoring in the general population after age 30 (every 5 years ...
Eligibility Criteria
Inclusion
- Women living with HIV
- Age 25-65 years
- Managed in the CHSD maternity ward: consultation or hospitalization
- Having signed a consent form
Exclusion
- Age ≤ 24 years, or ≥ 66 years
- Women who are not HIV positive
- Patients under legal protection (guardianship, curatorship)
- Patients deprived of liberty
- Patients not affiliated to a social security system
- Refusal to participate in the research
Key Trial Info
Start Date :
July 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05968183
Start Date
July 1 2023
End Date
October 1 2024
Last Update
August 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier de Saint-Denis
Saint-Denis, France